Table 2.
Comorbidities across stroke type, inpatient rehabilitation facilities (IRFs) and skilled nursing facilities (SNFs)
| All Stroke | Ischemic Stroke | Hemorrhagic Stoke | ||||
|---|---|---|---|---|---|---|
| (N=122,084) | N=108,128 (88.6%) | N=13,956 (11.4%) | ||||
| Comorbidities | IRF (N=66246) | SNF (N=55838) | IRF (N=59027) | SNF (N=49101) | IRF (N=7219) | SNF (N=6737) |
| Specified Heart Arrhythmias | 7291 (11.01%) | 8149 (14.59%) | 6503 (11.02%) | 7206 (14.68%) | 788 (10.92%) | 943 (14.00%) |
| Congestive Heart Failure | 6082 (9.18%) | 7079 (12.68%) | 5548 (9.40%) | 6377 (12.99%) | 534 (7.40%) | 702 (10.42%) |
| Diabetes without Complication | 6464 (9.76%) | 6256 (12.20%) | 5874 (9.95%) | 5582 (11.37%) | 590 (8.17%) | 674 (10.00%) |
| Chronic Obstructive Pulmonary Disease | 3945 (5.96%) | 4256 (7.62%) | 3555 (6.02%) | 3766 (7.67%) | 390 (5.40%) | 490 (7.27%) |
| Acute Renal Failure | 3517 (5.31%) | 3909 (7.00%) | 3144 (5.33%) | 3463 (7.05%) | 375 (5.17%) | 446 (6.62%) |
| Vascular Disease | 3146 (4.75%) | 3154 (5.65%) | 2863 (4.85%) | 2808 (5.72%) | 283 (3.92%) | 346 (5.14%) |
| Hemiplegia/Hemiparesis | 2788 (4.21%) | 2681 (4.80%) | 2555 (4.33%) | 2392 (4.87%) | 233 (3.23%) | 289 (4.29%) |
| Diabetes with Chronic Complications | 2018 (3.05%) | 1817 (3.25%) | 1850 (3.13%) | 1626 (3.31%) | 168 (2.33%) | 191 (2.84%) |
| Cardio-Respiratory Failure and Shock | 1433 (2.16%) | 1629 (2.92%) | 1273 (2.16%) | 1411 (2.87%) | 160 (2.22%) | 218 (3.24%) |
| Coagulation Defects and Other Specified Hematological Disorders | 1459 (2.20%) | 1468 (2.63%) | 1274 (2.16%) | 1245 (2.54%) | 185 (2.56%) | 223 (3.31%) |
| Septicemia, Sepsis, Systemic Inflammatory Response Syndrome/Shock | 1123 (1.70%) | 1404 (2.51%) | 993 (1.68%) | 1201 (2.45%) | 130 (1.80%) | 203 (3.01%) |
| Protein-Calorie Malnutrition | 979 (1.48%) | 1227 (2.20%) | 884 (1.50%) | 1043 (2.12%) | 95 (1.32%) | 184 (2.73%) |
| Seizure Disorders and Convulsions | 953 (1.44%) | 1242 (2.22%) | 811 (1.37%) | 1024 (2.09%) | 142 (1.97%) | 218 (3.24%) |
| Ischemic or Unspecified Stroke | 999 (1.51%) | 1184 (2.12%) | 932 (1.58%) | 1086 (2.21%) | 67 (0.93%) | 98 (1.45%) |
| Rheumatoid Arthritis and Inflammatory Connective Tissue Disease | 993 (1.50%) | 1022 (1.83%) | 907 (1.54%) | 910 (1.85%) | 86 (1.19%) | 112 (1.66%) |
| Morbid Obesity | 976 (1.47%) | 902 (1.62%) | 883 (1.50%) | 808 (1.65%) | 93 (1.29%) | 94 (1.40%) |
| Unstable Angina and Other Acute Ischemic Heart Disease | 650 (0.98%) | 690 (1.24%) | 585 (0.99%) | 613 (1.25%) | 65 (0.90%) | 77 (1.14%) |
| Other Significant Endocrine and Metabolic Disorders | 606 (0.91%) | 627 (1.12%) | 509 (0.86%) | 508 (1.03%) | 97 (1.34%) | 119 (1.77%) |
| Parkinson's and Huntington's Diseases | 497 (0.75%) | 636 (1.14%) | 458 (0.78%) | 548 (1.12%) | 39 (0.54%) | 88 (1.31%) |
| Major Depressive, Bipolar, and Paranoid Disorders | 422 (0.64%) | 594 (1.06%) | 385 (0.65%) | 513 (1.04%) | 37 (0.51%) | 81(1.20%) |
| Intestinal Obstruction/Perforation | 452 (0.68%) | 494 (0.88%) | 386 (0.65%) | 445 (0.91%) | 66 (0.91%) | 49 (0.73%) |
| Breast, Prostate, and Other Cancers and Tumors | 409 (0.62%) | 474 (0.85%) | 362 (0.61%) | 412 (0.84%) | 47 (0.65%) | 62 (0.92%) |
| Acute Myocardial Infarction | 413 (0.62%) | 449 (0.80%) | 375 (0.64%) | 396 (0.81%) | 38 (0.53%) | 53 (0.79%) |
| Cerebral Hemorrhage | 375 (0.57%) | 483 (0.87%) | 251 (0.43%) | 298 (0.61%) | 124 (1.72%) | 185 (2.75%) |
| Aspiration and Specified Bacterial Pneumonias | 330 (0.50%) | 411 (0.74%) | 287 (0.49%) | 344 (0.70%) | 43 (0.60%) | 67 (0.99%) |
| Vascular Disease with Complications | 362 (0.55%) | 401 (0.72%) | 300 (0.51%) | 358 (0.73%) | 62 (0.86%) | 43 (0.64%) |
| Chronic Ulcer of Skin, Except Pressure | 323 (0.49%) | 408 (0.73%) | 298 (0.50%) | 351 (0.71%) | 25 (0.35%) | 57 (0.85%) |
| Metastatic Cancer and Acute Leukemia | 358 (0.54%) | 349 (0.63%) | 299 (0.51%) | 282 (0.57%) | 59 (0.82%) | 67 (0.99%) |
| Coma, Brain Compression/Anoxic Damage | 353 (0.53%) | 351 (0.63%) | 232 (0.39%) | 200 (0.41%) | 121 (1.68%) | 151 (2.24%) |
| Artificial Openings for Feeding or Elimination | 329 (0.50%) | 332 (0.59%) | 291 (0.49%) | 277 (0.56%) | 38 (0.53%) | 55 (0.82%) |
Note.
†
, Chi-square test;
*
, significance at a α value of less than 0.05